BOSTON, Aug. 28, 2014 /PRNewswire/ -- The North American Thrombosis Forum (NATF), a non-profit organization dedicated to increasing public awareness of thrombosis and related cardiovascular diseases, is thrilled to welcome 7 renowned experts in cardiovascular medicine to speak at their Fall educational program, the 8th Annual Thrombosis Summit, on Saturday, September 20.
The Thrombosis Summit will take place at the beautiful Fairmont Copley Plaza Hotel located in Copley Square in Boston, from 7:30 AM until 11:50 AM. Boasting CME-accreditation, this educational program offers exclusive access to cutting-edge research in the management and prevention of heart attack, stroke, and pulmonary embolism (PE). Expert clinicians, including NATF President, Samuel Z. Goldhaber, MD, Paul Ridker, MD, and Christian T. Ruff, MD, MPH, will deliver intensive and interactive presentations to outline important updates in patient care for attendees from all disciplines of health care, caregivers, patients, and the public.
Thrombosis affects up to 600,000 Americans each year, yet public awareness of the disease is remarkably limited. The Summit program is intended to reduce this discrepancy through the sharing of knowledge about thrombosis and related diseases.
The Thrombosis Summit is sponsored in part by Astra-Zeneca. For more information, the full event agenda, and registration, go to www.regonline.com.
NATF is a 501c3 nonprofit organization that was established for the purpose of saving lives by stopping blood clots through prevention and education. Efforts are largely focused on novel research projects, educational programs, public policy initiatives, and patient advocacy.
To learn more, go to www.natfonline.org.
For more information, contact Kat Marriott, Assistant Director, at (617) 730-4120 or [email protected].
SOURCE North American Thrombosis Forum